Skip to main content
Premium Trial:

Request an Annual Quote

Viaken Partners with InforSense to Market Datamining and Visualization Platform

NEW YORK, July 23 - Viaken has partnered with e-science platform provider InforSense to market and distribute their large-scale genomic analysis and drug discovery platform, the companies announced Monday.

The platform, called the Kensington Discovery Edition, was developed by Copenhagen-based InforSense as networked-based software for data mining and analysis.

Terms of the agreement were not disclosed.

"The Kensington system provides the type of high-end enterprise scale data mining and visualization system that is required to manage and interpret the large volumes of complex data that are generated by today's drug discovery processes," Steve Gardner, chief technical officer of Viaken, said in a statement. "Kensington enables researchers to make more rapid and accurate decisions about R&D projects using a full range of statistical analysis and data mining tools."

Viaken, of Gaithersburg, Md, resells and hosts bioinformatics software applications, providing IT bioinformatics support to customers around the world. Unlike other genomics-related internet hubs, including those offered by DoubleTwist, Compugen, and eBioinformatics, Viaken does not develop proprietary software or content. 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.